ANTIGENIC CLOAKING AND ITS USE

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20120034254A1
SERIAL NO

12866723

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed are antigens that include a target epitope that is defined by atomic coordinates of those amino acids of the antigen that contact an antibody of interest that specifically binds the antigen. The disclosed antigens have between about 10% and about 90% of surface exposed amino acid residues located exterior of the target epitope substituted as compared to a wild-type antigen and less than about 10% of the non-surface exposed amino acid residues substituted as compared to a wild-type antigen. Also disclosed are nucleic acids encoding these antigens and methods of producing these antigens. Methods for generating an immune response in a subject are also disclosed. In some embodiments, the method is a method for treating or preventing a human immunodeficiency type 1 (HIV-1) infection in a subject.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AVERY DENNISON CORPORATION207 GOODE AVENUE GLENDALE CA 91203

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chen, Lei Rockville, US 979 4055
Do, Kwon Young Rockville, US 1 5
Kwong, Peter D Washington, US 48 271
Nabel, Gary J Washington, US 131 4161
Schief, William Seattle, US 12 24
Shaw, George Birmingham, US 23 1084
Yang, Zhi-yong Potomac, US 61 517
Zhou, Tongqing Boyds, US 44 202

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation